ciprofloxacin has been researched along with Deficiency, Factor 5 in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taniwaki, M | 1 |
| Katsutani, S | 1 |
| Yamasaki, M | 1 |
| Kawamoto, K | 1 |
| Funaishi, K | 1 |
| Matsumoto, Y | 1 |
| Matsumoto, N | 1 |
| Ohashi, N | 1 |
| Hattori, N | 1 |
1 other study available for ciprofloxacin and Deficiency, Factor 5
| Article | Year |
|---|---|
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report.
Topics: Aged; Anti-Bacterial Agents; Antibody Specificity; Antifungal Agents; Autoantibodies; Autoimmune Dis | 2019 |